立方制药
(003020)
| 流通市值：28.69亿 | | | 总市值：38.84亿 |
| 流通股本：1.69亿 | | | 总股本：2.28亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 684,259,649.21 | 357,096,223.21 | 1,553,801,538.88 | 1,080,686,112.23 |
| 营业总成本 | 593,492,800.85 | 316,973,192.5 | 1,411,384,496.9 | 979,333,366.51 |
| 其他经营收益 | | | | |
| 营业利润 | 95,867,771.07 | 41,798,046.68 | 182,107,183.12 | 137,103,382.16 |
| 利润总额 | 95,476,917.86 | 41,309,842.18 | 181,795,598.69 | 136,863,583.65 |
| 净利润 | 85,085,713.78 | 35,258,208.82 | 163,551,446.54 | 123,112,463.41 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 85,085,713.78 | 35,258,208.82 | 163,551,446.54 | 123,112,463.41 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,236,567,530.64 | 1,236,632,960.36 | 1,176,238,818.55 | 1,189,151,990.08 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,378,014,919.53 | 1,413,692,579.05 | 1,409,587,121.86 | 1,408,544,334.14 |
| 资产总计 | 2,614,582,450.17 | 2,650,325,539.41 | 2,585,825,940.41 | 2,597,696,324.22 |
| 流动负债: | | | | |
| 流动负债合计 | 506,503,094.75 | 542,188,203.37 | 520,580,823.44 | 538,142,982.35 |
| 非流动负债: | | | | |
| 非流动负债合计 | 128,416,204.6 | 121,080,585.93 | 113,613,025.33 | 114,099,737.36 |
| 负债合计 | 634,919,299.35 | 663,268,789.3 | 634,193,848.77 | 652,242,719.71 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,840,094,458.88 | 1,844,401,285.37 | 1,808,943,988.39 | 1,798,951,171.77 |
| 股东权益合计 | 1,979,663,150.82 | 1,987,056,750.11 | 1,951,632,091.64 | 1,945,453,604.51 |
| 负债和股东权益合计 | 2,614,582,450.17 | 2,650,325,539.41 | 2,585,825,940.41 | 2,597,696,324.22 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 848,552,226.36 | 434,245,732.58 | 1,737,425,551.49 | 1,300,473,614.31 |
| 经营活动现金流出小计 | 686,080,569.75 | 370,574,896.85 | 1,524,540,333.79 | 1,112,449,865.05 |
| 经营活动产生的现金流量净额 | 162,471,656.61 | 63,670,835.73 | 212,885,217.7 | 188,023,749.26 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 485,008,643.81 | 160,629,638.22 | 971,316,141.68 | 623,326,166.66 |
| 投资活动现金流出小计 | 802,742,865.47 | 360,129,805.62 | 1,030,316,422.41 | 702,982,899.62 |
| 投资活动产生的现金流量净额 | -317,734,221.66 | -199,500,167.4 | -59,000,280.73 | -79,656,732.96 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 30,077,855 | 10,000,000 | 1,165,821.75 | 0 |
| 筹资活动现金流出小计 | 71,731,889.98 | 2,922,641.56 | 180,792,044.18 | 145,466,764.44 |
| 筹资活动产生的现金流量净额 | -41,654,034.98 | 7,077,358.44 | -179,626,222.43 | -145,466,764.44 |
| 汇率变动对现金及现金等价物的影响 | -99,521.94 | -79,524.7 | -59,152.46 | -23,824.49 |
| 现金及现金等价物净增加额 | -197,016,121.97 | -128,831,497.93 | -25,800,437.92 | -37,123,572.63 |
| 期末现金及现金等价物余额 | 216,877,499.7 | 285,062,123.74 | 413,893,621.67 | 402,570,486.96 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -197,016,121.97 | - | -25,800,437.92 | - |